Caladrix Revenue

Biotechnology Research • • 1-10 Employees

Caladrix revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Caladrix

David Oxley

Member Board of Directors

Company overview

Headquarters	XX
Website	caladrix.bio
NAICS	541714
Keywords	Neurodegeneration, Tauopathies, Alzheimer’S Disease, Cns Drug Discovery, Translational Neuroscience, Abcc1 Modulation, Biomarker-Driven Medicine, Clinical Trials (Phase 1/2), Orally Available Therapeutics, Protein Clearance Biology
Founded	2025
Employees	1-10

About Caladrix

Caladrix is a CNS-focused biotechnology company pioneering disease-modifying therapeutics for Alzheimer’s and related tauopathies. Founded in Palo Alto in 2025, our mission is to harness the brain’s intrinsic clearance pathways—starting with ABCC1, a genetically validated efflux transporter that exports neurotoxic substrates such as amyloid-beta and inflammatory mediators. Our lead candidate, C-001, is an orally available small molecule designed to activate ABCC1. Unlike monoclonal antibody therapies, C-001 avoids ARIA risk, eliminates the need for infusion clinics, and directly restores the brain’s natural protein homeostasis. Preclinical efficacy, translational biomarker validation, and a successful human PoC study underpin our clinical development strategy. Caladrix’s Phase 1 trial begins in H1 2026. A 300-patient Phase 2 is slated for 2027. Our pipeline includes candidates for frontotemporal dementia and other tauopathies, as well as modified-release formulations to ensure scalability and adherence. With a strong IP estate, world-class collaborators, and a scientific team comprising Clarivate’s Highly Cited researchers, Caladrix is positioned to lead the next generation of non-immunologic neurodegenerative therapies. Palo Alto (HQ) | Melbourne (Clinical Trials) | Hamburg (R&D) Partner with us: bd@caladrix.bio | General: info@caladrix.bio

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Caladrix has never raised funding before.

Frequently asked questions

Caladrix is located in XX.

Caladrix generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Caladrix has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Caladrix was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

Caladrix has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Caladrix

David Oxley

Member Board of Directors

4.8

40,000 users